Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 22, 2011

Premium

Intrinsic Bioprobes this week launched three assays for protein biomarkers tied to kidney disease and renal failure.

The assays, which are based on the company's Mass Spectrometric Immunoassay technology, quantitate levels of beta-2-microglobulin, cystatin C, and retinol binding protein, which, the company said, are FDA-approved clinical markers for kidney disease and renal failure.

The assays will be offered out of the CLIA-certified diagnostic laboratory of the Institute for Genomics Medicine at the University of Medicine and Dentistry of New Jersey.


GE Healthcare this week launched its new Streptavidin Mag Sepharose magnetic beads and its MagRack Maxi magnetic rack.

The Mag Sepharose beads are for the purification of biotinylated biomolecules and have a more than 400-fold enrichment factor to enable increased identification of target proteins, the company said. The MagRack is designed to provide improved handling of samples.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.